# Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes

> **NCT06520839** · PHASE3 · RECRUITING · sponsor: **University Medical Centre Ljubljana** · enrollment: 90 (estimated)

## Conditions studied

- Erectile Dysfunction With Diabetes Mellitus

## Interventions

- **DRUG:** Tadalafil 5mg

## Key facts

- **NCT ID:** NCT06520839
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-17
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520839, "Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT06520839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*